RE:RE:what we don't know about the clinical dataFGPstock wrote:
DJD, how can you expect the stock you go up. they burried material information about the trial and their plans in the "interim financial statement". Other than ppl on stockhouse and ceo probably even red the NR. So, either your right, they are bad are marketing or don't want to advertise the success of the trial until they get their golden parachutes set...
Quite right. They are bad at marketing this technology.
If they are smart, they should contact with the FDA to get AA approval 1st, as the results are far better than that of Keytruda's (with less than half of patients in the trial of Keytruda).
So, in stead of waiting for the 25th patients of the 450-days data, they should force FDA to issue the AA approval 1st.
In this way, they can thus force Blowjobjoe's bosses to cover all of the historical naked shorted shares.
But as I said before, I doubt the management has that wit to do so.